Keratin-8-deficient mice develop chronic spontaneous Th2 colitis amenable to antibiotic treatment

被引:72
作者
Habtezion, A
Toivola, DM
Butcher, EC
Omary, MB
机构
[1] Palo Alto VA Med Ctr, Dept Med, Palo Alto, CA 94304 USA
[2] Palo Alto VA Med Ctr, Dept Pathol, Palo Alto, CA 94304 USA
[3] Stanford Univ, Sch Med, Ctr Digest Dis, Stanford, CA 94305 USA
关键词
colitis; inflammatory bowel disease; intermediate filaments; Th2; cytokine;
D O I
10.1242/jcs.02316
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Keratin 8 (K8) is the major intermediate filament protein present in intestinal epithelia. Depending on the mouse genetic background, absence of K8 causes embryonic lethality or colonic hyperplasia and colitis. We studied disease progression, the inflammatory responses, and role of luminal bacteria in K8-null mice in order to characterize the intestinal pathology of K8-associated colitis. Colon lymphocytes were isolated for analysis of their phenotype and cytokine production, and vascular and lymphocyte adhesion molecule expression in K8-/- mice of varying ages. K8-/- mice had a marked increase in TCR beta-positive/CD4-positive T cells infiltrating the colon lamina propria, in association with enhanced Th2 cytokine (IL-4, IL-5 and IL-13) production. K8-/- mice show early signs of inflammation even prior to weaning, that increases with age, and their epithelial cells overexpress MHC class II antigens. The chronic colitis is related to increased CD4-positive infiltrating T cells displaying memory and naive phenotypes, and an altered vascular endothelium with aberrant expression of peripheral node addressin. Analysis of normal gut-specific homing molecules, reveals an increased number Of alpha(4)beta(7)-positive cells and vascular mucosal addressin cell adhesion molecule-1 in K8-null colons. Antibiotic treatment markedly decreased colon inflammation and ion transporter AE1/2 mistargeting, indicating that luminal bacteria play an important role in the observed phenotype. Therefore, K8-null mice develop chronic spontaneous Th2-type colitis due to a primary epithelial rather than immune cell defect, which is amenable to antibiotic therapy. These mice provide a model to investigate epithelial-leukocyte and epithelial-microbial cross-talk.
引用
收藏
页码:1971 / 1980
页数:10
相关论文
共 43 条
[21]   Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice [J].
Madsen, KL ;
Doyle, JS ;
Tavernini, MM ;
Jewell, LD ;
Rennie, RP ;
Fedorak, RN .
GASTROENTEROLOGY, 2000, 118 (06) :1094-+
[22]   Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor [J].
Mashimo, H ;
Wu, DC ;
Podolsky, DK ;
Fishman, MC .
SCIENCE, 1996, 274 (5285) :262-265
[23]   EXPRESSION OF CLASS-II MOLECULES ON INTESTINAL EPITHELIAL-CELLS IN HUMANS - DIFFERENCES BETWEEN NORMAL AND INFLAMMATORY BOWEL-DISEASE [J].
MAYER, L ;
EISENHARDT, D ;
SALOMON, P ;
BAUER, W ;
PLOUS, R ;
PICCININI, L .
GASTROENTEROLOGY, 1991, 100 (01) :3-12
[24]  
MICHIE SA, 1993, AM J PATHOL, V143, P1688
[25]   Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease [J].
Mizoguchi, A ;
Mizoguchi, E ;
Chiba, C ;
Spiekermann, GM ;
Tonegawa, S ;
NaglerAnderson, C ;
Bhan, AK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :847-856
[26]   THE CATALOG OF HUMAN CYTOKERATINS - PATTERNS OF EXPRESSION IN NORMAL EPITHELIA, TUMORS AND CULTURED-CELLS [J].
MOLL, R ;
FRANKE, WW ;
SCHILLER, DL ;
GEIGER, B ;
KREPLER, R .
CELL, 1982, 31 (01) :11-24
[27]   ANTIBODIES TO INTERLEUKIN-12 ABROGATE ESTABLISHED EXPERIMENTAL COLITIS IN MICE [J].
NEURATH, MF ;
FUSS, I ;
KELSALL, BL ;
STUBER, E ;
STROBER, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1281-1290
[28]   Mechanisms of disease: Intermediate filament proteins and their associated diseases [J].
Omary, MB ;
Coulombe, PA ;
McLean, WHI .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (20) :2087-2100
[29]   Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients [J].
Owens, DW ;
Wilson, NJ ;
Hill, AJM ;
Rugg, EL ;
Porter, RM ;
Hutcheson, AM ;
Quinlan, RA ;
van Heel, D ;
Parkes, M ;
Jewell, DP ;
Campbell, SS ;
Ghosh, S ;
Satsangi, J ;
Lane, EB .
JOURNAL OF CELL SCIENCE, 2004, 117 (10) :1989-1999
[30]  
Panwala CM, 1998, J IMMUNOL, V161, P5733